DYRK1 (Dual specificity tyrosine phosphorylation regulated kinase 1) is a kinase enzyme involved in various cellular processes such as cell cycle regulation, gene expression, and neuronal development. Inhibition of DYRK1 has been studied as a potential therapeutic strategy for various diseases, including cancer, neurodegenerative disorders, and developmental disorders. Research on DYRK1 inhibition aims to understand the role of this enzyme in disease progression and identify potential small molecule inhibitors that can selectively target DYRK1 activity. By inhibiting DYRK1, researchers hope to regulate cellular processes that are dysregulated in diseases, such as cell proliferation, cell differentiation, and DNA repair. Overall, research on DYRK1 inhibition represents an exciting area of study with the potential to lead to the development of novel therapeutic interventions for a wide range of diseases.